About: Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence of Parkinson's disease in the elderly: The Rotterdam Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1995 (uk) im Dezember 1995 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1995 (ast) scientific article published on 01 December 1995 (en)
publication date	wds:Q57782167-D5062484-F728-4043-B69E-9EC1101F79A2
publication date	1995-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57782167-2A91D7D8-8668-4245-8130-E415694F4B18
language of work or name	English
author name string	wds:Q57782167-67D64BCD-C0EF-45F8-891A-80C66F1ADB28 wds:Q57782167-8EC6A366-10F5-44A9-9191-15F5B7EB9F1C wds:Q57782167-B51578B0-54A7-420A-8646-CABDA58B843B wds:Q57782167-C7CA7E0F-6F71-4A61-911E-98BA05595BEC wds:Q57782167-F4BE423B-CA47-4701-A325-DB9072EF47C8
author name string	D E Grobbee A Ott F G van der Meché M C de Rijk G A Graveland
rdfs:label	Prevalence of Parkinson's disease in the elderly: The Rotterdam Study (en) Prevalence of Parkinson's disease in the elderly: The Rotterdam Study (nl)
skos:prefLabel	Prevalence of Parkinson's disease in the elderly: The Rotterdam Study (en) Prevalence of Parkinson's disease in the elderly: The Rotterdam Study (nl)
name	Prevalence of Parkinson's disease in the elderly: The Rotterdam Study (en) Prevalence of Parkinson's disease in the elderly: The Rotterdam Study (nl)
author	wds:Q57782167-14892A99-56E1-457C-B1CA-9CDE158F0952 wds:Q57782167-B05E0366-5CDA-4932-A12E-5DAE7DDDD3AE
author	Monique Breteler Albert Hofman
title	wds:Q57782167-D38A7217-DBB6-4632-9452-6455DB78C4B1
title	Prevalence of Parkinson's disease in the elderly: the Rotterdam Study (en)
page(s)	wds:Q57782167-82631FC7-6124-4D99-B7F6-98F284581241
page(s)	2143-2146
instance of	wds:Q57782167-CE31858D-C496-49F7-BE3F-D3759CA8E15F
instance of	scholarly article
main subject	wds:Q57782167-7A29C144-D280-4E81-B3E9-2FEDD63516C9
main subject	Parkinson's disease
PubMed ID	wds:Q57782167-61807CB0-905C-4852-A89C-4A809A599790
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8848182
PubMed ID	8848182
published in	wds:Q57782167-EADCABB2-7335-45DF-82AF-A2DDB7BBEABB
published in	Neurology
issue	wds:Q57782167-CA725D7E-3733-40A0-A016-1F708D4FB736
volume	wds:Q57782167-812E406F-37A3-4A3A-B20D-D6F610CBCD3F
issue	12
volume	45
DOI	wds:Q57782167-93216955-B384-4BB2-88AA-6CD6A0010328
DOI	http://dx.doi.org/10.1212/WNL.45.12.2143
DOI	10.1212/WNL.45.12.2143
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57782167
is cites work of	The health burdens of Parkinson's disease. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker Selegiline, or the problem of early termination of clinical trials. The clinical questions are not well answered, and probably never will be. Mutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease Epidemiology of Parkinson's disease Neurological benefits of omega-3 fatty acids Epidemiological evidence on multiple system atrophy Sestrin2 Protects Dopaminergic Cells against Rotenone Toxicity through AMPK-Dependent Autophagy Activation Prevalence of Parkinson's disease in lower Aragon, Spain Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey. The Rotterdam Study: objectives and design update Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders Mild Parkinsonian signs: An overview of an emerging concept The prevalence of Parkinson's disease: a systematic review and meta-analysis Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study Differential expression of the parkin gene in the human brain and peripheral leukocytes Origin and functional consequences of the complex I defect in Parkinson's disease Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology? Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations Study of the prevalence of Parkinson's disease using dopamine transporter imaging The Rotterdam Study: 2012 objectives and design update Hormone replacement therapy and risk for neurodegenerative diseases. Neuroprotective actions of sex steroids in Parkinson's disease Parkinson's disease Decreased circulating Zinc levels in Parkinson's disease: a meta-analysis study The Rotterdam Study: 2016 objectives and design update Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007 Impaired intracellular trafficking defines early Parkinson's disease Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review The Rotterdam Study: 2010 objectives and design update Progressive supranuclear palsy: where are we now? wd:Q64968130 A metabolomic study of brain tissues from aged mice with low expression of the vesicular monoamine transporter 2 (VMAT2) gene Aging in fragile X syndrome. How valid is the clinical diagnosis of Parkinson's disease in the community? Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research The retina in Parkinson's disease Genetic and environmental risk factors in Parkinson's disease. Genes and parkinsonism. Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software